Evidence map›Paper›PMID 39133649›Full record

ArticleJCI insight2024

Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy.

Keishiro Fukumoto, Shigeaki Kanatani, Georg Jaremko, Zoe West, Yue Li, Kimiharu Takamatsu, Ibrahim Al Rayyes, Shuji Mikami, Naoya Niwa, Tomas Andri Axelsson and 5 more

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Keishiro FukumotoDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Shigeaki KanataniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Georg JaremkoDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Zoe WestDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Yue LiDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Kimiharu TakamatsuDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Ibrahim Al RayyesDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Shuji MikamiDepartment of Diagnostic Pathology, National Hospital Organization Saitama Hospital, Saitama, Japan.
Naoya NiwaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Tomas Andri AxelssonDivision of Urology, Danderyd Hospital, Stockholm, Sweden.
Nobuyuki TanakaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Mototsugu OyaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Ayako MiyakawaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Marianne BrehmerDepartment of Urology and Department of Clinical Science and Education, Stockholm South General Hospital, Sweden.
Per UhlénDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upper tract urothelial carcinoma (UTUC) is a rare form of urothelial cancer with a high incidence of recurrence and a low survival rate. Almost two-thirds of UTUCs are invasive at the time of diagnosis; therefore, improving diagnostic methods is key to increasing survival rates. Histopathological analysis of UTUC is essential for diagnosis and typically requires endoscopy biopsy, tissue sectioning, and labeling. However, endoscopy biopsies are minute, and it is challenging to cut into thin sections for conventional histopathology; this complicates diagnosis. Here, we used volumetric 3-dimensional (3D) imaging to explore the inner landscape of clinical UTUC biopsies, without sectioning, revealing that 3D analysis of phosphorylated ribosomal protein S6 (pS6) could predict tumor grade and prognosis with improved accuracy. By visualizing the tumor vasculature, we discovered that pS6+ cells were localized near blood vessels at significantly higher levels in high-grade tumors than in low-grade tumors. Furthermore, the clustering of pS6+ cells was associated with shorter relapse-free survival. Our results demonstrate that 3D volume imaging of the structural niches of pS6 cells deep inside the UTUC samples improved diagnostic yield, grading, and prognosis prediction.

Indexed as

Imaging, Three-DimensionalAgedBiopsyCarcinoma, Transitional CellFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalPrognosisRibosomal Protein S6Urologic NeoplasmsUrotheliumRibosomal Protein S6OncologySignal transductionUrology

Identifiers

PMID39133649
PMCPMC11383588

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.